openPR Logo
Press release

Diabetic Retinopathy Market Outlook 2025: Trends, Innovations, and Growth Drivers | Top Companies are Abbott Laboratories, Alimera Science, Allergan plc.

06-27-2025 08:37 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Diabetic Retinopathy

Diabetic Retinopathy

The Global Diabetic Retinopathy Market reached US$ 7,167.00 million in 2023 and is expected to reach US$ 11,702.89 million by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.

The Diabetic Retinopathy Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders and their innovative approaches to product development, competitive pricing models, financial performance, and expansion strategies. The research unveils critical market forces, competitive positioning, and breakthrough trends that will define the industry's trajectory in the coming years, providing stakeholders with actionable intelligence to navigate this rapidly evolving marketplace.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/diabetic-retinopathy-market?rk

Diabetic retinopathy is a diabetes complication that affects the eyes by damaging the blood vessels of the light-sensitive tissue at the back of the eye (retina). It is one of the leading causes of blindness in adults and can occur in anyone who has type 1 or type 2 diabetes. The diabetic retinopathy market includes diagnostic devices, treatment options like anti-VEGF drugs, corticosteroids, laser surgeries, and vitrectomy procedures.

Market Trends:

Rising Diabetes Prevalence: Increasing global incidence of diabetes is directly boosting demand for diabetic retinopathy diagnosis and treatment solutions.

Technological Advancements: Integration of AI in retinal imaging and diagnostic tools is improving early detection and clinical outcomes.

Preference for Non-Invasive Treatments: There is a growing shift toward intravitreal injections and minimally invasive procedures.

Focus on Combination Therapies: Combining laser treatments with anti-VEGF drugs is showing better long-term outcomes in patients.

Diabetic Retinopathy Market: Industry Giants and Emerging Leaders:

Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals, Bayer AG, Hoffmann-La Roche, Novartis International AG, Glycadia Pharmaceuticals, Regeneron Pharmaceuticals Inc and Valeant Pharmaceutical.

Diabetic Retinopathy Industry News:

Several biotech companies have launched clinical trials for next-gen anti-VEGF biosimilars with extended dosing intervals.

AI-driven diagnostic platforms have been incorporated into routine screening workflows in hospitals and ophthalmology clinics.

Novel sustained-release implants are being developed to reduce the frequency of intravitreal injections.

Public health initiatives in countries like India and Brazil have scaled up diabetic retinopathy screening programs at the community level.

Research Methodology

Our comprehensive research approach leverages a dual-methodology framework that seamlessly integrates qualitative insights with quantitative data analysis to deliver robust market intelligence. The process begins with extensive secondary research, where we meticulously collect information from authoritative industry publications, proprietary databases, and verified market sources. This foundation is strengthened through targeted primary research initiatives, including strategic surveys and in-depth interviews with industry veterans, market experts, and key stakeholders.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/diabetic-retinopathy-market

Segment Covered in the Diabetic Retinopathy Market:

By Indication Type: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy.

By Treatment Type: Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery, Vitrectomy.

By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

Regional Analysis for Diabetic Retinopathy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)



Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Diabetic Retinopathy market?

➠ Who are the global key manufacturers of the Diabetic Retinopathy Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Diabetic Retinopathy market opportunities and threats faced by the vendors in the global Diabetic Retinopathy Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Diabetic Retinopathy market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking For Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=diabetic-retinopathy-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Retinopathy Market Outlook 2025: Trends, Innovations, and Growth Drivers | Top Companies are Abbott Laboratories, Alimera Science, Allergan plc. here

News-ID: 4084429 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Plant Breeding and CRISPR Plant Market Outlook 2024-2031: Innovations in Genome Editing, Crop Yield, and Sustainable Agriculture | Bayer AG, BASF, Syngenta Crop Protection AG.
United States Plant Breeding and CRISPR Plant Market Outlook 2024-2031: Innovati …
Plant Breeding and CRISPR Plant Market is forecasted to reach at a CAGR of 10.87% during the forecast period (2024-2031). This market focuses on improving crop yield, quality, and resistance through modern breeding techniques and CRISPR-based genome editing. Plant breeding innovations support food security by developing climate-resilient and pest-resistant varieties. CRISPR technology enables precise genetic modifications, reducing time compared to conventional breeding. Market growth is driven by increasing global food demand
Recent Developments in Neuromorphic Computing: Intel, IBM, Qualcomm, Fujitsu, Sony, and Global Research Institutions Driving Innovation
Recent Developments in Neuromorphic Computing: Intel, IBM, Qualcomm, Fujitsu, So …
The Global Neuromorphic Computing Market reached USD 48.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,801.9 million by 2030. The global neuromorphic computing market is expected to exhibit a CAGR of 91.5% during the forecast period (2024-2031). The neuromorphic computing market revolves around hardware and systems modeled on the human brain's neural architecture, enabling advanced processing and learning capabilities. These systems aim to
Strategic Collaborations in Electric Aircraft Charging Infrastructure: Partnerships Between Aerospace Firms, Energy Companies, and Airports | Rolls-Royce Holdings Plc, Beta Technologies, Electro.Aero Pty Ltd.
Strategic Collaborations in Electric Aircraft Charging Infrastructure: Partnersh …
Global Electric Aircraft Charging Interfaces Market reached USD 0.54 billion in 2023 and is expected to reach USD 2.1 billion by 2031 growing with a CAGR of 20.7% during the forecast period 2024-2031. This market involves charging systems and interfaces that enable electric and hybrid-electric aircraft to recharge efficiently and safely. With the aviation industry pushing toward sustainable solutions, these interfaces are critical for commercial, private, and urban air mobility vehicles.
Anti-Obesity Drugs Market Recent Developments 2025: Key Updates from the U.S., Europe, Japan, and Asia-Pacific | Major Companies are Eli Lilly and Company, Bayer AG, Bristol-Myers Squibb
Anti-Obesity Drugs Market Recent Developments 2025: Key Updates from the U.S., E …
Global Anti-Obesity Drugs Market reached US$ 2.5 billion in 2022 and is expected to reach US$ 43.7 billion by 2030 growing with a CAGR of 45.5% during the forecast period 2024-2031. The anti-obesity drugs market includes pharmaceuticals designed to promote weight loss by suppressing appetite, reducing fat absorption, or enhancing energy expenditure. Rising global obesity rates, linked to sedentary lifestyles and unhealthy diets, are driving market demand. Approved drugs include orlistat,

All 5 Releases


More Releases for Diabetic

Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth? The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report. On the basis of
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282 Global Diabetic Socks Market: Factors Impacting the Market The primary factors driving the growth of the global diabetic socks market are increasing
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be